Impact of prior antihypertensive treatment on COVID-19 outcomes, by active ingredient.
García-Álvarez RM, Zapata-Cachafeiro M, Visos-Varela I, Rodríguez-Fernández A, Pintos-Rodríguez S, Piñeiro-Lamas M, Herdeiro TM, Figueiras A, Salgado-Barreira A; COVID-Drug Group.
García-Álvarez RM, et al. Among authors: rodriguez fernandez a.
Inflammopharmacology. 2024 Apr 15. doi: 10.1007/s10787-024-01475-2. Online ahead of print.
Inflammopharmacology. 2024.
PMID: 38619761